Why We Desperately Need to Develop New Antifungals
While serious fungal infections are rare, there is a limited number of approved drugs to…
06/09/2021 - 10 minutes
Infectious disease
Chikungunya Vaccine First to Succeed in Phase III Trial
In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya…
19/08/2021 - 3 minutes
Sanofi’s Translate Bio Buyout Shows Growing Hunger for mRNA Technology
Sanofi’s acquisition of its partner Translate Bio is a clear sign that pharmaceutical companies are…
17/08/2021 - 5 minutes
Scotland’s Top 10 Biotech Companies to Watch Out For
Scotland has a thriving life sciences ecosystem with strengths in oncology, genetic engineering, and industrial…
30/06/2021 - 11 minutes
Next-Generation mRNA Vaccine Technology Unveiled in Series A Round
Messenger RNA vaccines have been at the forefront of the global struggle against the Covid-19…
01/06/2021 - 4 minutes
Changing Attitudes on Vaccine and Public Health Investment
The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will…
21/04/2021 - 5 minutes
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
20/04/2021 - 5 minutes
How Vaccine Platforms Can Prepare Us for Future Pandemics
The Covid-19 pandemic exposed the weaknesses in our defenses. Vaccine platforms will be a powerful…
15/02/2021 - 6 minutes
Universal Flu Vaccines Yield Second Clinical Failure This Year
In a blow to hopes for better protection from seasonal flu, last week’s phase III…
29/10/2020 - 5 minutes
How Immuno-Oncology Contributes to the Fight Against Covid-19
As the Covid-19 pandemic sweeps the world, cancer research is proving a valuable resource for…
06/07/2020 - 7 minutes
CureVac Bids to Develop First mRNA Coronavirus Vaccine
RNA vaccine developer CureVac will receive a grant of up to €8.3M from a global…
03/02/2020 - 2 minutes
Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development
The UK biotech Emergex Vaccines has raised over €9.9M in a Series A funding round,…
09/01/2020 - 3 minutes
